MMB-CHMICA
Overview[edit | edit source]
MMB-CHMICA is a synthetic cannabinoid that has been used in scientific research and recreational drug use. It is a potent agonist of the cannabinoid receptors, primarily the CB1 receptor, and is known for its psychoactive effects. MMB-CHMICA is part of a class of compounds known as designer drugs, which are often created to mimic the effects of cannabis while avoiding legal restrictions.
Chemical Structure[edit | edit source]
MMB-CHMICA is chemically classified as an indole-based synthetic cannabinoid. Its structure includes a methyl ester group, which is a common feature in many synthetic cannabinoids. The compound is known for its high affinity and selectivity for the CB1 receptor, which contributes to its potent psychoactive effects.
Pharmacology[edit | edit source]
MMB-CHMICA acts as a full agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The activation of this receptor by MMB-CHMICA leads to a range of effects, including altered perception, mood changes, and cognitive impairment. The compound's high potency and efficacy at the CB1 receptor make it a subject of interest in both pharmacological research and forensic analysis.
Legal Status[edit | edit source]
Due to its potential for abuse and lack of medical use, MMB-CHMICA has been classified as a controlled substance in many jurisdictions. It is often included in legislation targeting new psychoactive substances (NPS) and synthetic cannabinoids. The legal status of MMB-CHMICA can vary significantly between countries, with some having specific bans on the compound and others including it under broader synthetic cannabinoid regulations.
Health Effects[edit | edit source]
The use of MMB-CHMICA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and anxiety. In severe cases, use of the compound can lead to psychosis, seizures, and even death. The variability in the potency and purity of synthetic cannabinoids like MMB-CHMICA further complicates the risk profile for users.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
